The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB)
Abstract
Multidrug-resistant bacteria (MDRB) are extremely dangerous and bring a serious threat to health care systems as they can survive an attack from almost any drug. The bacteria’s adaptive way of living with the use of antimicrobials and antibiotics caused them to modify and prevail in hostile conditions by creating resistance to known antibiotics or their combinations. The emergence of nanomaterials as new antimicrobials introduces a new paradigm for antibiotic use in various fields. For example, silver nanoparticles (AgNPs) are the oldest nanomaterial used for bactericide and bacteriostatic purposes. However, for just a few decades these have been produced in a biogenic or bio-based fashion. This review brings the latest reports on biogenic AgNPs in the combat against MDRB. Some antimicrobial mechanisms and possible silver resistance traits acquired by bacteria are also presented. Hopefully, novel AgNPs-containing products might be designed against MDR bacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Direct contact of AgNPs with large surface areas on a bacterial cell wall could lead to membrane damage, resulting in the leakage of cellular contents and eventual cell death [139,140,141,142].”
From Bactericidal and Cytotoxic Properties of Silver Nanoparticles (2019) · cites this paper as [142]
In the citing paper
“The killing effect of AgNPs have been proposed to be associated with a direct contact of nanoparticles to the bacterial cell wall, followed by penetrating into cytoplasm.”
From Bactericidal and Cytotoxic Properties of Silver Nanoparticles (2019) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Theory, Production and Mechanism of Formation of Monodispersed Hydrosols
LaMer, V. K., & Dinegar, R. H. (1950) · Journal of the American Chemical Society · doi:10.1021/ja01167a001 · Cited by 3,894
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
The global threat of antimicrobial resistance: science for intervention.
Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.02.007 · Cited by 1,106 · cited 1×
“The number of pathogens presenting multidrug resistance has had an exponential increase in recent times and is considered an important problem for public health [3].”
BackgroundCombination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625 · cited 2×
“The use of drugs combinations, two or more antimicrobial drugs to combat MDRB [7], is already employed in cancer therapy [8], HIV-patients [9], and malaria patients [10].”
Background
Research works printed but not linked: 162
- Littier, 2017, Animal agriculture as a contributor to the global challenge of antibiotic resistance, CAB Rev., 8, 1, 10.1079/PAVSNNR201712003 · doi:10.1079/pavsnnr201712003
- Huebner, 2016, Economic burden of multidrug-resistant bacteria in nursing homes in Germany: A cost analysis based on empirical data, BJM Open, 6, e008458
- Lane, 2006, Designer combination therapy for cancer, Nat. Biotechnol., 24, 163, 10.1038/nbt0206-163 · DOI
- Richman, 2001, HIV chemotherapy, Nature, 410, 995, 10.1038/35073673 · DOI · Paper page
- Nosten, 2007, Artemisinin-based combination treatment of falciparum malaria, Am. J. Trop. Med. Hyg., 77, 191, 10.4269/ajtmh.2007.77.181 · DOI · Paper page
- Xiao, 2018, Chemo-enzymatic synthesis of poly (4-piperidine lactone-b-ω-pentadecalactone) block copolymers as biomaterials with antibacterial properties, Biomacromolecules, 19, 2673, 10.1021/acs.biomac.8b00296 · DOI
- Zoriasatein, 2018, Evaluation of antimicrobial properties of derivative peptide of Naja naja snake’s venom, World Fam. Med. J., 16, 44, 10.5742/MEWFM.2018.93382 · DOI
- Hamzah, 2018, Evaluation of Phyllanthus emblica extract as antibacterial and antibiofilm against biofilm formation, TIJAS, 49, 142
- Naqvi, 2013, Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria, Int. J. Nanomed., 8, 3187, 10.2147/IJN.S49284 · DOI · Paper page
- Sirelkhatim, 2015, Review on zinc oxide nanoparticles: Antibacterial activity, Nano-Micro Lett., 7, 219, 10.1007/s40820-015-0040-x · DOI · Paper page
- Ingle, 2014, Bioactivity, mechanism of action, and cytotoxicity of copper-based nanoparticles: A review, Appl. Microbiol. Biotechnol., 98, 1001, 10.1007/s00253-013-5422-8 · DOI · Paper page
- Dinali, 2017, Iron oxide nanoparticles in modern microbiology and biotechnology, Crit. Rev. Microb., 43, 493, 10.1080/1040841X.2016.1267708 · DOI · Paper page
- Dastjerdi, 2010, A review on the application of inorganic nano-structured materials in the modification of textiles: Focus on anti-microbial properties, Colloids Surf. B Biointerfaces, 79, 5, 10.1016/j.colsurfb.2010.03.029 · DOI · Paper page
- Ballottin, 2017, Antimicrobial textiles: Biogenic silver nanoparticles against Candida and Xanthomonas, Mater. Sci. Eng. C, 75, 582, 10.1016/j.msec.2017.02.110 · DOI
- Ertem, 2017, Core-shell silver nanoparticles in endodontic disinfection solutions enable long-term antimicrobial effect on oral biofilms, ACS Appl. Mater. Interfaces, 9, 34762, 10.1021/acsami.7b13929 · DOI
- Grumezescu, A. (2016). Use of nanoparticles as a potential antimicrobial for food packaging. Food Preservation, Academic Press. [1st ed.].
- Holtz, 2012, Nanostructured silver vanadate as a promising antibacterial additive to water-based paints, Nanomed. NBM, 8, 935, 10.1016/j.nano.2011.11.012 · DOI
- Rai, 2012, Silver nanoparticles: The powerful nanoweapon against multidrug-resistant bacteria, J. Appl. Microb., 112, 841, 10.1111/j.1365-2672.2012.05253.x · DOI · Paper page
- Radetic, 2013, Functionalization of textile materials with silver nanoparticles, J. Mater. Sci., 48, 95, 10.1007/s10853-012-6677-7 · DOI · Paper page
- Maneerung, 2008, Impregnation of silver nanoparticles into bacterial cellulose for antimicrobial wound dressing, Carbohydr. Polym., 72, 43, 10.1016/j.carbpol.2007.07.025 · DOI · Paper page
- Chen, 2006, Effect of silver nanoparticles dressing on second degree burn wound, Zhonghua Wai Ke Za Zhi, 44, 50
- Muangman, 2006, Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds, J. Med. Assoc. Thail., 89, 953
- Cohen, 2007, In vitro analysis of a nanocrystalline silver-coated surgical mesh, Surg. Infect., 8, 397, 10.1089/sur.2006.032 · DOI · Paper page
- Lansdown, 2006, Silver in health care: Antimicrobial effects and safety in use, Curr. Probl. Dermatol., 33, 17, 10.1159/000093928 · DOI · Paper page
- Zhang, 2007, Study on germicidal efficacy and toxicity of compound disinfectant gel of nanometer silver and chlorhexidine acetate, Chin. J. Health Lab. Technol., 17, 1403
- Zhang, 2007, A study on the bio-safety for nano-silver as anti-bacterial materials, Chin. J. Med. Instrum., 31, 35
- Nowack, 2011, 120 Years of nanosilver history: Implications for policy makers, Environ. Sci. Technol., 45, 1177, 10.1021/es103316q · DOI · Paper page
- Waksman, 1973, History of the word ‘antibiotic’, J. Hist. Med. Allied Sci., 28, 284, 10.1093/jhmas/XXVIII.3.284 · DOI
- Davies, 2010, Origins and evolution of antibiotic resistance, Microbiol. Mol. Biol. Rev., 74, 417, 10.1128/MMBR.00016-10 · DOI · Paper page
- Williams, 2009, The introduction of ‘chemotherapy’ using arsphenamine—The first magic bullet, J. R. Soc. Med., 102, 343, 10.1258/jrsm.2009.09k036 · DOI
- Izumi, 2001, Modern Japanese medical history and the European influence, Keio J. Med., 50, 91, 10.2302/kjm.50.91 · DOI
- Amivov, 2010, A brief history of the antibiotic era: Lessons learned and challenges for the future, Front. Microbiol., 1, 134
- Bbosa, 2014, Antibiotics/antibacterial drug use, their marketing and promotion during the post-antibiotic golden age and their role in emergence of bacterial resistance, Health, 6, 410, 10.4236/health.2014.65059 · DOI
- Thal, 1999, Occurrence and epidemiology of resistance to virginiamycin and streptogramins, J. Antimicrob. Chemother., 43, 171, 10.1093/jac/43.2.171 · DOI
- Manten, 1969, Development of drug resistance to rifampicin, Chemotherapy, 14, 93, 10.1159/000220615 · DOI
- Schönfeld, W., and Kirst, H. (2002). Introduction to the macrolide antibiotics. Macrolide Antibiotics Milestones in Drug Therapy MDT, Birkhäuser. · doi:10.1007/978-3-0348-8105-0
- Jacoby, 2005, Mechanisms of resistance to quinolones, Clin. Infect. Dis., 41, S120, 10.1086/428052 · DOI · Paper page
- Madhavan, 2013, Farewell, chloramphenicol? Is this true?: A review, J. Microbiol. Biotechnol., 3, 13
- Mutnick, 2003, Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program, Ann. Pharmacother., 37, 769, 10.1345/aph.1C437 · DOI
- Abraham, 1940, An enzyme from bacteria able to destroy penicillin, Rev. Infect. Dis., 10, 677
- Davies, 1995, Vicious circles: Looking back on resistance plasmids, Genetics, 139, 1465, 10.1093/genetics/139.4.1465 · DOI
- Funnell, B., and Philips, G. (2004). Introduction to plasmids: A selective view of their history. Plasmid Biology, ASM Press. · doi:10.1128/9781555817732
- Hacker, 2000, Pathogenicity islands and the evolution of microbes, Annu. Rev. Microbiol., 54, 641, 10.1146/annurev.micro.54.1.641 · DOI · Paper page
- Steward, 2001, Antibiotic resistance of bacteria in biofilms, Lancet, 358, 135, 10.1016/S0140-6736(01)05321-1 · DOI · Paper page
- Andersson, 2003, Persistence of antibiotic resistant bacteria, Curr. Opin. Microbiol., 6, 452, 10.1016/j.mib.2003.09.001 · DOI · Paper page
- Nikaido, 2009, Multidrug Resistance in Bacteria, Annu. Rev. Biochem., 78, 119, 10.1146/annurev.biochem.78.082907.145923 · DOI · Paper page
- Kirbis, 2015, Spread of antibiotic resistant bacteria from food of animal origin to humans and vice versa, Procedia Food Sci., 5, 148, 10.1016/j.profoo.2015.09.043 · DOI
- 2015, The Antibiotic Resistance Crisis—Part 1: Causes and Threats, Pharm. Ther., 40, 277
- Paterson, 2016, Multidrug resistant bacteria in the community: Trends and lessons learned, Infect. Dis. Clin. N. Am., 30, 377, 10.1016/j.idc.2016.02.004 · DOI · Paper page
- Davies, 2006, Where have all the antibiotics gone?, Can. J. Infect. Dis. Med. Microbiol., 17, 287, 10.1155/2006/707296 · DOI · Paper page
- (2018, June 10). Why Are There So Few Antibiotics in the Research and Development Pipeline?. Available online: https://www.pharmaceutical-journal.com/news-and-analysis/features/why-are-there-so-few-antibiotics-in-the-research-and-development-pipeline/11130209.article.
- Thakkar, 2010, Biological synthesis of metallic nanoparticles, Nanomed. NBM, 6, 257, 10.1016/j.nano.2009.07.002 · DOI · Paper page
- Silveira, 2015, Silver nanoparticle protein corona and toxicity: A mini-review, J. Nanobiotechnol., 13, 1
- Ballottin, 2016, Elucidating protein involvement in the stabilization of the biogenic silver nanoparticles, Nanoscale Res. Lett., 11, 1, 10.1186/s11671-016-1538-y · DOI
- Shannahan, 2014, Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors, Toxicol. Sci., 143, 136, 10.1093/toxsci/kfu217 · DOI · Paper page
- Rai, M., and Bridge, P.D. (2009). Myconanotechnology: A new and emerging science. Applied Mycology, CABI. · doi:10.1079/9781845935344.0000
- Zhao, 2017, Fungal silver nanoparticles: Synthesis, application and challenges, Crit. Rev. Biotechnol., 38, 817, 10.1080/07388551.2017.1414141 · DOI · Paper page
- Ahmad, 2003, Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum, Colloids Surf. B, 28, 313, 10.1016/S0927-7765(02)00174-1 · DOI · Paper page
- Marcato, 2005, Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains, J. Nanobiotechnol., 3, 8, 10.1186/1477-3155-3-8 · DOI · Paper page
- Scandorieiro, 2016, Synergistic and additive effect of oregano essential oil and biological silver nanoparticles against multidrug-resistant bacterial strains, Front. Microbiol., 7, 760, 10.3389/fmicb.2016.00760 · DOI · Paper page
- Graves, 2015, Rapid evolution of silver nanoparticle resistance in Escherichia coli, Front. Genet., 6, 42, 10.3389/fgene.2015.00042 · DOI · Paper page
- Chowdhury, 2014, Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus Macrophomina phaseolina (Tassi) Goid with antimicrobial properties against multidrug-resistant bacteria, Nanoscale Res. Lett., 9, 365, 10.1186/1556-276X-9-365 · DOI
- Neethu, 2018, Green synthesized silver nanoparticles by marine endophytic fungus Penicillium polonicum and its antibacterial efficacy against biofilm forming, multidrug-resistant Acinetobacter baumanii, Microb. Pathog., 116, 263, 10.1016/j.micpath.2018.01.033 · DOI · Paper page
- Gopinath, 2015, Mycosynthesis, characterization and antibacterial properties of AgNPs against multidrug resistant (MDR) bacterial pathogens of female infertility cases, Asian J. Pharm. Sci., 10, 138, 10.1016/j.ajps.2014.08.007 · DOI
- Fayaz, 2010, Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: A study against gram-positive and gram-negative bacteria, Nanomed. NBM, 6, 103, 10.1016/j.nano.2009.04.006 · DOI · Paper page
- Bhat, 2015, Exploitation of filamentous fungi for biosynthesis of silver nanoparticle and its enhanced antibacterial activity, Int. J. Pharm. Biol. Sci., 6, 506
- Ray, 2011, Extracellular biosynthesis of silver nanoparticles using the mycorrhizal mushroom Tricholoma crassum (Berk.) SACC: Its antimicrobial activity against pathogenic bacteria and fungus, including multidrug resistant plant and human bacteria, Dig. J. Nanomater. Biostruct., 6, 1289
- Dhanasekaran, 2013, Extracellular biosynthesis, characterisation and in-vitro antibacterial potential of silver nanoparticles using Agaricus bisporus, J. Exp. Nanosci., 8, 579, 10.1080/17458080.2011.577099 · doi:10.1080/17458080.2011.577099
- Saravanan, 2010, Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE, Colloids Surf. B Biointerfaces, 77, 214, 10.1016/j.colsurfb.2010.01.026 · doi:10.1016/j.colsurfb.2010.01.026
- Dar, 2013, Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics, Nanomed. NBM, 9, 105, 10.1016/j.nano.2012.04.007 · DOI · Paper page
- Hiremath, 2014, Antibacterial activity of silver nanoparticles from Rhizopus spp against Gram negative E. coli-MDR strains, J. Pure Appl. Microbiol., 8, 555
- Singh, 2015, Bacteriagenic silver nanoparticles: Synthesis, mechanism, and applications, Appl. Microbiol. Biotechnol., 99, 4579, 10.1007/s00253-015-6622-1 · DOI · Paper page
- Saifuddin, 2009, Rapid biosynthesis of silver nanoparticles using culture supernatant of bacteria with microwave irradiation, E-J. Chem., 6, 61, 10.1155/2009/734264 · DOI · Paper page
- Zhang, 2016, Light-induced reduction of silver ions to silver nanoparticles in aquatic environments by microbial extracellular polymeric substances (EPS), Water Res., 106, 242, 10.1016/j.watres.2016.10.004 · doi:10.1016/j.watres.2016.10.004
- Klaus, 1999, Silver-based crystalline nanoparticles, microbially fabricated, Proc. Natl. Acad. Sci. USA, 96, 13611, 10.1073/pnas.96.24.13611 · DOI · Paper page
- Joerger, 2001, Bacteria as workers in the living factory: Metal-accumulating bacteria and their potential for materials science, Trends Biotechnol., 19, 15, 10.1016/S0167-7799(00)01514-6 · DOI · Paper page
- Kalishwaralal, 2010, Biosynthesis of silver and gold nanoparticles using Brevibacterium casei, Colloids Surf. B, 77, 257, 10.1016/j.colsurfb.2010.02.007 · DOI · Paper page
- Singh, 2017, Biosynthesis of silver nanoparticles using Aeromonas sp. THG-FG1.2 and its antibacterial activity against pathogenic microbes, Artif. Cells Nanomed. Biotechnol., 45, 584, 10.3109/21691401.2016.1163715 · DOI
- Desai, 2016, Hydrothermal assisted biosynthesis of silver nanoparticles from Streptomyces sp. GUT 21 (KU500633) and its therapeutic antimicrobial activity, J. Nanostruct. Chem., 6, 235, 10.1007/s40097-016-0197-y · doi:10.1007/s40097-016-0197-y
- Manikprabhu, 2016, Sunlight mediated synthesis of silver nanoparticles by a novel actinobacterium (Sinomonas mesophila MPKL 26) and its antimicrobial activity against multi drug resistant Staphylococcus aureus, J. Photochem. Photobiol., 158, 202, 10.1016/j.jphotobiol.2016.01.018 · doi:10.1016/j.jphotobiol.2016.01.018
- Santos, K.S., Barbosa, A.M., Costa, L.P., Pinheiro, M.S., Oliveira, M.B.P.P., and Padilha, F.F. (2016). Silver nanocomposite biosynthesis: Antibacterial activity against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Molecules, 21. · DOI
- Subashini, 2014, Anti-ESBL activity of silver nanoparticles biosynthesized using soil Streptomyces species, Bioprocess Biosyst. Eng., 37, 999, 10.1007/s00449-013-1070-8 · DOI
- Thomas, 2014, Antibacterial activity and synergistic effect of biosynthesized AgNPs with antibiotics against multidrug-resistant biofilm-forming coagulase-negative Staphylococci isolated from clinical samples, Appl. Biochem. Biotechnol., 173, 449, 10.1007/s12010-014-0852-z · DOI
- Arul, 2017, Antibacterial efficacy of silver nanoparticles and ethyl acetate’s metabolites of the potent halophilic (marine) bacterium, Bacillus cereus A30 on multidrug resistant bacteria, Pathog. Glob. Health, 111, 367, 10.1080/20477724.2017.1390829 · DOI
- Lateef, 2015, Biogenic synthesis of silver nanoparticles using cell-free extract of Bacillus safensis LAU 13: Antimicrobial, free radical scavenging and larvicidal activities, Biologia, 70, 1295, 10.1515/biolog-2015-0164 · doi:10.1515/biolog-2015-0164
- Jain, 2010, Novel microbial route to synthesize silver nanoparticles using spore crystal mixture of Bacillus thuringiensis, Indian J. Exp. Biol., 48, 1152
- Singh, 2014, Green synthesis of silver nanoparticles using cell extracts of Anabaena doliolum and screening of its antibacterial and antitumor activity, J. Microbiol. Biotechnol., 24, 1354, 10.4014/jmb.1405.05003 · DOI
- Saravanan, 2011, Rapid biosynthesis of silver nanoparticles from Bacillus megaterium (NCIM 2326) and their antibacterial activity on multi drug resistant clinical pathogens, Colloids Surf. B Biointerfaces, 88, 325, 10.1016/j.colsurfb.2011.07.009 · DOI · Paper page
- Priyadarshini, 2013, Synthesis of anisotropic silver nanoparticles using novel strain, Bacillus flexus and its biomedical application, Colloids Surf. B Biointerfaces, 102, 232, 10.1016/j.colsurfb.2012.08.018 · DOI · Paper page
- Saravanan, 2018, Synthesis of silver nanoparticles from Bacillus brevis (NCIM 2533) and their antibacterial activity against pathogenic bacteria, Microb. Pathog., 116, 221, 10.1016/j.micpath.2018.01.038 · DOI · Paper page
- Ahmed, 2016, A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise, J. Adv. Res., 7, 17, 10.1016/j.jare.2015.02.007 · DOI · Paper page
- Prathna, 2011, Biomimetic synthesis of silver nanoparticles by Citrus limon (lemon) aqueous extract and theoretical prediction of particle size, Colloids Surf. B Biointerfaces, 82, 152, 10.1016/j.colsurfb.2010.08.036 · DOI · Paper page
- Jiang, 2010, Role of citric acid in the formation of silver nanoplates through a synergistic reduction approach, Langmuir, 26, 4400, 10.1021/la903470f · DOI · Paper page
- Makarov, 2014, Green nanotechnologies: Synthesis of metal nanoparticles using plants, Acta Naturae, 6, 35, 10.32607/20758251-2014-6-1-35-44 · DOI · Paper page
- Singh, 2010, Biosynthesis of gold and silver nanoparticles by natural precursor clove and their functionalization with amine group, J. Nanopart. Res., 12, 1667, 10.1007/s11051-009-9835-3 · DOI · Paper page
- Barros, 2018, Bio-based synthesis of silver nanoparticles from orange waste: Effects of distinct biomolecule coatings on size, morphology, and antimicrobial activity, Nanotechnol. Sci. Appl., 11, 1, 10.2147/NSA.S156115 · DOI
- Ma, 2017, Antibacterial evaluation of silver nanoparticles synthesized by polysaccharides from Astragalus membranaceus roots, Biomed. Pharmacother., 89, 351, 10.1016/j.biopha.2017.02.009 · DOI
- Anjum, 2016, Biomimetic synthesis of antimicrobial silver nanoparticles using in vitro-propagated plantlets of a medicinally important endangered species: Phlomis bracteosa, Int. J. Nanomed., 11, 1663
- Jeeva, 2012, Caesalpinia coriaria leaf extracts mediated biosynthesis of metallic silver nanoparticles and their antibacterial activity against clinically isolated pathogens, Ind. Crops Prod., 52, 714, 10.1016/j.indcrop.2013.11.037 · DOI
- Jinu, 2017, Biofabrication of cubic phase silver nanoparticles loaded with phytochemicals from Solanum nigrum leaf extracts for potential antibacterial, antibiofilm and antioxidant activities against MDR human pathogens, J. Clust. Sci., 28, 489, 10.1007/s10876-016-1125-5 · DOI
- Prasannaraj, 2017, Enhanced antibacterial, anti-biofilm and antioxidant (ROS) activities of biomolecules engineered silver nanoparticles against clinically isolated Gram positive and Gram negative microbial pathogens, J. Clust. Sci., 28, 645, 10.1007/s10876-017-1160-x · DOI
- Das, 2017, Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage, Arab. J. Chem., 10, 862, 10.1016/j.arabjc.2015.08.008 · DOI
- Gopinath, 2013, Biogenic synthesis of antibacterial silver chloride nanoparticles using leaf extracts of Cissus quadrangularis Linn, Mater. Lett., 91, 224, 10.1016/j.matlet.2012.09.102 · doi:10.1016/j.matlet.2012.09.102
- Khalil, 2014, Green synthesis of silver nanoparticles using olive leaf extract and its antibacterial activity, Arab. J. Chem., 7, 1131, 10.1016/j.arabjc.2013.04.007 · DOI · Paper page
- Singh, 2014, Green silver nanoparticles of Phyllanthus amarus: As an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa, J. Nanobiotechnol., 12, 40, 10.1186/s12951-014-0040-x · DOI
- Kasithevar, 2017, Antibacterial efficacy of silver nanoparticles against multi-drug resistant clinical isolates from post-surgical wound infections, Microb. Pathog., 107, 327, 10.1016/j.micpath.2017.04.013 · doi:10.1016/j.micpath.2017.04.013
- Gopinath, 2012, Biosynthesis of silver nanoparticles from Tribulus terrestris and its antimicrobial activity: A novel biological approach, Colloids Surf. B Biointerfaces, 96, 69, 10.1016/j.colsurfb.2012.03.023 · DOI · Paper page
- Veerasamy, 2011, Biosynthesis of silver nanoparticles using mangosteen leaf extract and evaluation of their antimicrobial activities, J. Saudi Chem. Soc., 15, 113, 10.1016/j.jscs.2010.06.004 · DOI
- Singh, 2012, Biosynthesis of silver nanoparticles using Ricinus communis L. leaf extract and its antibacterial activity, Dig. J. Nanomater. Biostruct., 7, 1157
- Prakash, 2013, Green synthesis of silver nanoparticles from leaf extract of Mimusops elengi, Linn. for enhanced antibacterial activity against multi drug resistant clinical isolates, Colloids Surf. B Biointerfaces, 108, 255, 10.1016/j.colsurfb.2013.03.017 · doi:10.1016/j.colsurfb.2013.03.017
- Garg, 2017, In vitro antibacterial activity of biosynthesized silver nanoparticles from ethyl acetate extract of Hydrocotyle sibthorpioides against multidrug resistant microbes, Asian J. Pharm. Clin. Res., 10, 263, 10.22159/ajpcr.2017.v10i6.17976 · doi:10.22159/ajpcr.2017.v10i6.17976
- Li, 2017, Making good use of the byproducts of cultivation: Green synthesis and antibacterial effects of silver nanoparticles using the leaf extract of blueberry, J. Food Sci. Technol., 54, 3569, 10.1007/s13197-017-2815-1 · doi:10.1007/s13197-017-2815-1
- Miri, 2015, Plant-mediated biosynthesis of silver nanoparticles using Prosopis farcta extract and its antibacterial properties, Spectrochim. Acta A Mol. Biomol. Spectrosc., 141, 287, 10.1016/j.saa.2015.01.024 · DOI
- Das, 2013, Sesbania grandiflora leaf extract mediated green synthesis of antibacterial silver nanoparticles against selected human pathogens, Spectrochim. Acta A Mol. Biomol. Spectrosc., 104, 265, 10.1016/j.saa.2012.11.075 · DOI
- Lateef, 2016, Biogenic synthesis of silver nanoparticles using a pod extract of Cola nitida: Antibacterial and antioxidant activities and application as a paint additive, J. Taibah Univ. Sci., 10, 551, 10.1016/j.jtusci.2015.10.010 · DOI · Paper page
- Kagithoju, 2015, Eco-friendly and green synthesis of silver nanoparticles using leaf extract of Strychnos potatorum Linn.F. and their bactericidal activities, 3 Biotech, 5, 709, 10.1007/s13205-014-0272-3 · doi:10.1007/s13205-014-0272-3
- Prabakar, 2013, Evaluation of antibacterial efficacy of phyto fabricated silver nanoparticles using Mukia scabrella (Musumusukkai) against drug resistance nosocomial gram negative bacterial pathogens, Colloids Surf. B Biointerfaces, 104, 282, 10.1016/j.colsurfb.2012.11.041 · doi:10.1016/j.colsurfb.2012.11.041
- Meva, 2017, Natural substances for the synthesis of silver nanoparticles against Escherichia coli: The case of Megaphrynium macrostachyum (Marantaceae), Corchorus olitorus (Tiliaceae), Ricinodendron heudelotii (Euphorbiaceae), Gnetum bucholzianum (Gnetaceae), and Ipomoea batatas (Convolvulaceae), J. Nanomater., 2017, 6834726
- Shruthi, 2017, Green synthesis of biologically active silver nanoparticles through a phyto-mediated approach using Areca catechu leaf extract, ChemistrySelect, 2, 10354, 10.1002/slct.201702257 · doi:10.1002/slct.201702257
- Azeez, 2017, Biomedical applications of cocoa bean extract-mediated silver nanoparticles as antimicrobial, larvicidal and anticoagulant agents, J. Clust. Sci., 28, 149, 10.1007/s10876-016-1055-2 · DOI
- Lateef, 2016, Cocoa pod husk extract-mediated biosynthesis of silver nanoparticles: Its antimicrobial, antioxidant and larvicidal activities, J. Nanostruct. Chem., 6, 159, 10.1007/s40097-016-0191-4 · doi:10.1007/s40097-016-0191-4
- Swamy, 2015, Synthesis and characterization of silver nanoparticles using fruit extract of Momordica cymbalaria and assessment of their in vitro antimicrobial, antioxidant and cytotoxicity activities, Spectrochim. Acta A Mol. Biomol. Spectrosc., 151, 939, 10.1016/j.saa.2015.07.009 · DOI · Paper page
- Jesus, 2016, Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity, Nanomed. NBM, 12, 789, 10.1016/j.nano.2015.11.016 · DOI · Paper page
- Li, 2008, Antimicrobial nanomaterials for water disinfection and microbial control: Potential applications and implications, Water Res., 42, 4591, 10.1016/j.watres.2008.08.015 · DOI · Paper page
- Manke, 2013, Mechanisms of nanoparticle-induced oxidative stress and toxicity, BioMed Res. Int., 2013, 942916, 10.1155/2013/942916 · DOI · Paper page
- Siddiqi, 2018, A review on biosynthesis of silver nanoparticles and their biocidal properties, J. Nanobiotechnol., 16, 14, 10.1186/s12951-018-0334-5 · DOI · Paper page
- Zheng, 2018, Antimicrobial silver nanomaterials, Coord. Chem. Rev., 357, 1, 10.1016/j.ccr.2017.11.019 · DOI · Paper page
- Lok, 2006, Proteomic analysis of the mode of antibacterial action of silver nanoparticles, J. Proteome Res., 5, 916, 10.1021/pr0504079 · DOI · Paper page
- Xiu, 2012, Negligible particle-specific antibacterial activity of silver nanoparticles, Nano Lett., 12, 4271, 10.1021/nl301934w · DOI · Paper page
- Dibrov, 2002, Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae, Antimicrob. Agents Chemother., 46, 2668, 10.1128/AAC.46.8.2668-2670.2002 · DOI · Paper page
- Liau, 1997, Interaction of silver nitrate with readily identifiable groups: Relationship to the antibacterial action of silver ions, Lett. Appl. Microbiol., 25, 279, 10.1046/j.1472-765X.1997.00219.x · DOI · Paper page
- Liao, 2017, Targeting the thioredoxin reductase–thioredoxin system from Staphylococcus aureus by silver ions, Inorg. Chem., 56, 14823, 10.1021/acs.inorgchem.7b01904 · DOI
- Holt, 2005, Interaction of silver(I) ions with the respiratory chain of Escherichia coli: An electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+, Biochemistry, 44, 13214, 10.1021/bi0508542 · DOI · Paper page
- Wen, 2013, Binding of cytoskeletal proteins with silver nanoparticles, RSC Adv., 3, 22002, 10.1039/c3ra43281e · DOI
- Hong, 2016, Shape effect on the antibacterial activity of silver nanoparticles synthesized via a microwave-assisted method, Environ. Sci. Pollut. Res., 23, 4489, 10.1007/s11356-015-5668-z · DOI · Paper page
- Alshareef, 2017, Shape-dependent antibacterial activity of silver nanoparticles on Escherichia coli and Enterococcus faecium bacterium, Appl. Surf. Sci., 424, 310, 10.1016/j.apsusc.2017.03.176 · DOI
- Pal, 2007, Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli, Appl. Environ. Microb., 73, 1712, 10.1128/AEM.02218-06 · DOI · Paper page
- Acharya, 2018, Shape dependent physical mutilation and lethal effects of silver nanoparticles on bacteria, Sci. Rep., 8, 201, 10.1038/s41598-017-18590-6 · DOI · Paper page
- Ivask, A., Kurvet, I., Kasemets, K., Blinova, I., Aruoja, V., Suppi, S., Vija, H., Kakinen, A., Titma, T., and Heinlaan, M. (2014). Size-dependent toxicity of silver nanoparticles to bacteria, yeast, algae, crustaceans and mammalian cells in vitro. PLoS ONE, 9. · DOI · Paper page
- Kumari, 2017, Tailoring shape and size of biogenic silver nanoparticles to enhance antimicrobial efficacy against MDR bacteria, Microb. Pathog., 105, 346, 10.1016/j.micpath.2016.11.012 · doi:10.1016/j.micpath.2016.11.012
- Lu, 2013, Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria, J. Mater. Sci. Mater. Med., 24, 1465, 10.1007/s10856-013-4894-5 · DOI · Paper page
- Chen, 2011, Antimicrobial activity and the mechanism of silver, Int. J. Nanomed., 6, 2873
- Kora, 2018, Biogenic silver nanoparticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cytotoxicity and its mode of action, Arab. J. Chem., 11, 313, 10.1016/j.arabjc.2014.10.036 · DOI
- Kim, 2007, Antimicrobial effects of silver nanoparticles, Nanomed. NBM, 3, 95, 10.1016/j.nano.2006.12.001 · DOI · Paper page
- Choi, 2008, Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria, Environ. Sci. Technol., 42, 4583, 10.1021/es703238h · DOI · Paper page
- Li, 2010, Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli, Appl. Microbiol. Biotechnol., 85, 1115, 10.1007/s00253-009-2159-5 · DOI · Paper page
- Ahmad, 2017, The effects of bacteria-nanoparticles interface on the antibacterial activity of green synthesized silver nanoparticles, Microb. Pathog., 102, 133, 10.1016/j.micpath.2016.11.030 · DOI · Paper page
- Qayyum, S., Oves, M., and Khan, A.U. (2017). Obliteration of bacterial growth and biofilm through ROS generation by facilely synthesized green silver nanoparticles. PLoS ONE, 12. · DOI · Paper page
- Pareek, 2018, Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review, Mater. Sci. Eng. C, 90, 739, 10.1016/j.msec.2018.04.093 · DOI · Paper page
- Mchugh, 1975, Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin, Lancet, 1, 235, 10.1016/S0140-6736(75)91138-1 · DOI · Paper page
- Gupta, 1999, Molecular basis for resistance to silver cations in Salmonella, Nat. Med., 5, 183, 10.1038/5545 · DOI · Paper page
- Finley, 2015, Unprecedented silver resistance in clinically isolated Enterobacteriaceae: Major implications for burn and wound management, Antimicrob. Agents Chemother., 59, 4734, 10.1128/AAC.00026-15 · doi:10.1128/aac.00026-15
- Li, 1997, Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins, J. Bacteriol., 179, 6127, 10.1128/jb.179.19.6127-6132.1997 · DOI · Paper page
- Randall, 2015, Silver resistance in Gram-negative bacteria: A dissection of endogenous and exogenous mechanisms, J. Antimicrob. Chemother., 70, 1037, 10.1093/jac/dku523 · DOI · Paper page
- Su, 2011, Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli, Nature, 470, 558, 10.1038/nature09743 · DOI · Paper page
- Xue, 2008, Cu(I) recognition via cation-π and methionine interactions in CusF, Nat. Chem. Biol., 4, 107, 10.1038/nchembio.2007.57 · DOI · Paper page
- Gudipaty, 2014, The histidine kinase CusS senses silver ions through direct binding by its sensor domain, Biochim. Biophys. Acta, 1844, 1656, 10.1016/j.bbapap.2014.06.001 · DOI
- Franke, 2001, The product of the ybdE gene of the Escherichia coli chromosome is involved in detoxification of silver ions, Microbiology, 147, 965, 10.1099/00221287-147-4-965 · DOI · Paper page
- Prucek, 2018, Bacterial resistance to silver nanoparticles and how to overcome it, Nat. Nanotechnol., 13, 65, 10.1038/s41565-017-0013-y · DOI · Paper page
- Liang, 2016, Novel asymmetric wettable AgNPs/chitosan wound dressing: In vitro and in vivo evaluation, ACS Appl. Mater. Interfaces, 8, 3958, 10.1021/acsami.5b11160 · DOI · Paper page
- Yabanoglu, 2013, Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats, Int. Surg., 98, 416, 10.9738/INTSURG-D-13-00017.1 · doi:10.9738/intsurg-d-13-00017.1
- Huang, 2007, A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis, Burns, 33, 161, 10.1016/j.burns.2006.06.020 · DOI · Paper page
Cited by
Bactericidal and Cytotoxic Properties of Silver Nanoparticles
Liao, C., Li, Y., & Tjong, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020449 · Cited by 1,180
Nanoparticle–Biofilm Interactions: The Role of the EPS Matrix
Fulaz, S., Vitale, S., Quinn, L., & Casey, E. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.07.004 · Cited by 562
Self-citationBactericidal activity of silver nanoparticles: A mechanistic review
Anees Ahmad, S., Sachi Das, S., Khatoon, A., Tahir Ansari, M., Afzal, M., Saquib Hasnain, M., & Kumar Nayak, A. (2020) · Materials Science for Energy Technologies · doi:10.1016/j.mset.2020.09.002 · Cited by 541
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Lee, N.-Y., Ko, W.-C., & Hsueh, P.-R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01153 · Cited by 532
Parvekar, P., Palaskar, J., Metgud, S., Maria, R., & Dutta, S. (2020) · Biomaterial Investigations in Dentistry · doi:10.1080/26415275.2020.1796674 · Cited by 426
Metadata
- Authors
- Barros, C. H. N., Fulaz, S., Stanisic, D., & Tasic, L.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2018-08-02
- Volume
- 7
- Issue
- 3
- Pages
- 69
- ISSN
- 2079-6382
- Cited by
- 104
- References
- 6
- Language
- en
- Funders
- Fundação de Amparo à Pesquisa de São Paulo (2015/12534-5 and 2014/50867-3)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (465389/201407)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB). https://app.cochat.ai/papers/10.3390/antibiotics7030069
- The paper
- Barros, C. H. N., Fulaz, S., Stanisic, D., & Tasic, L. (2018). Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB). Antibiotics. https://doi.org/10.3390/antibiotics7030069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.